bf/NASDAQ:AZN_icon.jpeg

NASDAQ:AZN

AstraZeneca PLC

  • Stock

USD

Last Close

64.16

01/03 21:00

Market Cap

208.00B

Beta: 0.17

Volume Today

3.90M

Avg: 4.68M

PE Ratio

34.25

PFCF: 28.96

Dividend Yield

2.22%

Payout:75.97%

  • industry

    Drug Manufacturers / General
  • exchange

    NASDAQ Global Select
  • website

    www.astrazeneca.com
  • ipo date

    Aug 29, 2001
  • full time employees

    83,500
  • currency

    USD

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology...Show More

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.